Translation of Molecular Pathways into Clinical Trials of Neuroendocrine Tumors

Neuroendocrinology, 04/13/2012

Pavel M – The review provides a broad overview of established and potential molecular targets in neuroendocrine tumors (NET), summarizes data from phase II and III clinical trials with targeted drugs and outlines future therapeutic directions.

Print Article Summary

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List